ISSN 2639-9431
Vol. 4, Issue 2, 2021June 25, 2021 EDT
Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19
Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19
Articles in Vol. 4, Issue 2, 2021
Vol. 4, Issue 2, 2021
- Cellular uptake of nanoparticles: Involvement of caveolae?Tore SkotlandTore Geir IversenKirsten Sandvig
- Nanotechnology to deliver cannabinoids in dermatologyNagasai C. AdusumilliElizabeth L. HazukaAdam J. Friedman
- Pulmonary and intranasal delivery of thymoquinone-loaded nanoparticles for Mucormycosis & Covid-19Andrei SommerHorst-Dieter FörsterlingKurt NaberRamasamy Pitchappan
- ViroStatics Testing Capabilities to Determine Efficacy of Drugs, Disinfectants or Devices against SARS-CoV-2Barbara PoddesuGiulia CugiaFranco LoriDavide De Forni
Sommer, Andrei, Horst-Dieter Försterling, Kurt Naber, and Ramasamy Pitchappan. 2021. “Pulmonary and Intranasal Delivery of Thymoquinone-Loaded Nanoparticles for Mucormycosis & Covid-19.” Precision Nanomedicine 4 (2): 795–800. https://doi.org/10.33218/001c.24963.